Regulatory T Cell Involvement in Melanoma Prognosis and Treatment Strategy
Source: Dermatology Learning Network, March 2024
According to a recent study published in Environmental Toxicology, regulatory T cells (Tregs) play a crucial role in immune suppression within the melanoma microenvironment.
Researchers analyzed single-cell RNA sequencing data alongside clinical information. The study identified distinct cell subsets within the tumor microenvironment, including various immune and stromal cell types. Subsequent analyses revealed the functional differences among these cell subsets, particularly highlighting the immunomodulatory role of Tregs. Furthermore, the study delineated Treg subpopulations and identified molecular pathways associated with their interaction with melanoma cells, notably implicating the ITGB2 signaling pathway.
A novel prognostic model based on Treg-associated risk scores was developed and validated, demonstrating robust predictive capabilities for melanoma prognosis. This model, independent of traditional clinical factors, holds promise for evaluating patient outcomes and potentially guiding immunotherapy decisions. Additionally, immune infiltration analysis and assessment of immune checkpoint gene expression provided further insights into the clinical relevance of the prognostic model.